Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H23ClN2S.ClH |
| Molecular Weight | 383.378 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCN(CC)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
InChI
InChIKey=XXQMDKCWUYZXOF-UHFFFAOYSA-N
InChI=1S/C19H23ClN2S.ClH/c1-3-21(4-2)12-7-13-22-16-8-5-6-9-18(16)23-19-11-10-15(20)14-17(19)22;/h5-6,8-11,14H,3-4,7,12-13H2,1-2H3;1H
Chlorproethazine (Neuriplege) is a neuroleptic, antipsychotic and muscle relaxant. Neuriplege® cream was available as a non‐prescription medication in France until its withdrawal from the market by regulatory authorities in January 2007. Neuriplege caused phototoxicity and photocontact allergy.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Hypothermia increases interleukin-6 and interleukin-10 in juvenile endotoxemic mice. | 2010-01 |
|
| Toxic effects of chlorpromazine on Carassius auratus and its oxidative stress. | 2008-11 |
|
| Comparative effects of cationic triarylmethane, phenoxazine and phenothiazine dyes on horse serum butyrylcholinesterase. | 2008-10-15 |
|
| Photocontact allergic and phototoxic studies of chlorproethazine. | 2008-02 |
|
| Combined quinacrine and chlorpromazine therapy in fatal familial insomnia. | 2004-08-21 |
|
| Contact sensitization to chlorproethazine can induce persistent light reaction and cross-photoreactions to other phenothiazines. | 2001-06 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C66880
Created by
admin on Mon Mar 31 18:31:01 GMT 2025 , Edited by admin on Mon Mar 31 18:31:01 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID10196726
Created by
admin on Mon Mar 31 18:31:01 GMT 2025 , Edited by admin on Mon Mar 31 18:31:01 GMT 2025
|
PRIMARY | |||
|
C054028
Created by
admin on Mon Mar 31 18:31:01 GMT 2025 , Edited by admin on Mon Mar 31 18:31:01 GMT 2025
|
PRIMARY | |||
|
SUB01252MIG
Created by
admin on Mon Mar 31 18:31:01 GMT 2025 , Edited by admin on Mon Mar 31 18:31:01 GMT 2025
|
PRIMARY | |||
|
100000084720
Created by
admin on Mon Mar 31 18:31:01 GMT 2025 , Edited by admin on Mon Mar 31 18:31:01 GMT 2025
|
PRIMARY | |||
|
225-018-8
Created by
admin on Mon Mar 31 18:31:01 GMT 2025 , Edited by admin on Mon Mar 31 18:31:01 GMT 2025
|
PRIMARY | |||
|
169470
Created by
admin on Mon Mar 31 18:31:01 GMT 2025 , Edited by admin on Mon Mar 31 18:31:01 GMT 2025
|
PRIMARY | |||
|
C77983
Created by
admin on Mon Mar 31 18:31:01 GMT 2025 , Edited by admin on Mon Mar 31 18:31:01 GMT 2025
|
PRIMARY | |||
|
71829
Created by
admin on Mon Mar 31 18:31:01 GMT 2025 , Edited by admin on Mon Mar 31 18:31:01 GMT 2025
|
PRIMARY | |||
|
520P4U8V2Z
Created by
admin on Mon Mar 31 18:31:01 GMT 2025 , Edited by admin on Mon Mar 31 18:31:01 GMT 2025
|
PRIMARY | |||
|
m3459
Created by
admin on Mon Mar 31 18:31:01 GMT 2025 , Edited by admin on Mon Mar 31 18:31:01 GMT 2025
|
PRIMARY | Merck Index | ||
|
236297
Created by
admin on Mon Mar 31 18:31:01 GMT 2025 , Edited by admin on Mon Mar 31 18:31:01 GMT 2025
|
PRIMARY | RxNorm | ||
|
CHEMBL52125
Created by
admin on Mon Mar 31 18:31:01 GMT 2025 , Edited by admin on Mon Mar 31 18:31:01 GMT 2025
|
PRIMARY | |||
|
4611-02-3
Created by
admin on Mon Mar 31 18:31:01 GMT 2025 , Edited by admin on Mon Mar 31 18:31:01 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD
